eBook: Why is antibody development so important?

MedImmune, nascent biologic, merrimack, INSERM, Hoffmann-La Roche, Hospices Civils de Lyon, antibodies, ADC, Bispecific, e-book

Would knowing how the leaders in the field of antibodies think therapeutic development will continue over the next 5 years be of benefit to you?  Would knowing what they want to discuss, and where they plan on having these discussions be useful information to your business?  Whether you are looking to maintain, develop or enter the exciting field of antibody therapeutics, knowing how and what the industry is thinking is priceless information!

DOWNLOAD the complete interviews of 6 innovative thinkers from across the fields of mAbs, ADCs and bispecific antibodies for free!

Representatives from MedImmune, Nascent Biologics, Merrimack Pharmaceuticals, INSERM, Hoffmann-La Roche and Hospices Civils de Lyon & Université Lyon 1

If you want to find out more then you need to attend the 8th annual European Antibody CongressDOWNLOAD the brochure for the complete agenda.

Would you like to find out more?

New format European Antibody Congress 2012

Antibody development in the next 5 years

For more updates on pharma, biotech and R&D, follow us on Twitter: @biopharmaevents or join our LinkedIn group: BioPharma- Networking for Pharmaceuticals, Biotech and R&D

Leave a Reply

Your email address will not be published. Required fields are marked *